Remdeathisvir killed a friend of mine. Kidneys shut down,
Remdeathisvir killed a friend of mine. Kidneys shut down, lungs filled with fluid and he died. Wife wanted ivermectin, but hospital would not allow. I later learned that in order for hospitals to get the $70,000 covid death incentive payment, they had to exactly follow the US governments treatment protocol, which meant the use of Remdeathisvir. BTW, my friend was a large shareholder of CYDY and a big believer in Leronlimab. He was a smart successful business owner and careful investor, and CYDY is the only otc stock he ever played. He studied it forwards and backwards before investing in it. He loved CYDY and loved talking about the huge potential. The world is a worse place without him.
23
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Faraday Future's Commitment to Global Expansion Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) continues to make significant strides in its global expansion amid a rapidly evolving electric mobility market. As the company forges ahead, it prides itself on its innovative technology and strategic partnerships that aim to drive its mission of transforming the...
Continue Reading
In 2024, financial independence without a job can be attained by laying a strong financial basis, creating passive income, and using digital assets. Long-term investments, prudent saving and spending practices, and ongoing education are all necessary. More help can come from using government programs and forming a support system. Success is mostly dependent on planning...
Continue Reading
Allison Transmission Declares Dividend for Shareholders Allison Transmission Holdings Inc. (NYSE: ALSN) has recently made an important announcement regarding its cash dividend for shareholders. The company's Board of Directors has approved a dividend of $0.27 per share on the common stock for the third quarter. This reflects Allison's commitment to providing value to its...
Continue Reading
Overview of the Investigation into aTyr Pharma Inc. aTyr Pharma, Inc. (NASDAQ: ATYR), a biotechnology company, is currently under investigation due to potential securities fraud allegations. The inquiry focuses on whether the company misled investors or failed to disclose vital information necessary for informed decision-making. This investigation has significant...
Continue Reading
Lyte Fiber Launches Advanced Internet Services for Baytown Lyte Fiber, LLC is excited to announce the development of a groundbreaking fiber network designed specifically for the needs of residents and businesses in Baytown. This project marks Lyte's debut in the telecom market and represents a significant investment aimed at enhancing internet connectivity in the area....
Continue Reading
